reac-technology
Contact us
reac-technology
Contact us

REAC Technology: A Groundbreaking Therapeutic Approach for Alzheimer’s and Neurodegenerative Diseases

REAC neuromodulation shows promise for Alzheimer’s non-invasive, no side effects, boosts neuronal differentiation and counters senescence.

  • June 16, 2025
A-novel-neuromodulation-technology-in-Alzheimer’s

The global search for an effective cure for Alzheimer’s Disease (AD) and other neurodegenerative conditions remains one of modern medicine’s most significant challenges. While pharmacological therapies have shown limited success, the scientific community is actively exploring alternative strategies, with neurostimulation by physical means emerging as a particularly promising field.

In this context, a pivotal scientific paper titled “Radio electric asymmetric conveyer: a novel neuromodulation technology in Alzheimer’s and other neurodegenerative diseases” synthesizes the promising results of Radio Electric Asymmetric Conveyer (REAC) technology in this field. The study, led by Prof. Salvatore Rinaldi and Dr. Vania Fontani, the inventors of the technology, highlights how REAC is distinctly different from other neurostimulation techniques.

A Unique and Non-Invasive Technology

Unlike other methods, REAC technology is not based on the intensity of its emission but on a weak, asymmetric interaction with the body. Through a special “asymmetric conveyer” probe, REAC is able to interact with the body’s endogenous bio-electric microcurrents, optimizing cellular function in a non-invasive, painless manner, and with no known side effects.

The Efficacy of REAC: From Cell to Clinic

The article summarizes an impressive body of evidence demonstrating the efficacy of REAC technology on multiple levels:

  1. Human Clinical Studies: Patients with late-stage Alzheimer’s, treated with the Neuro Postural Optimization (NPO) protocol, have shown significant improvements in gait and balance. Other studies have confirmed the effectiveness of REAC treatments in enhancing cognitive functions and behavioral disorders associated with AD, all with a high safety and tolerability profile.
  2. Animal Model Studies: Research on mouse models of AD has demonstrated that exposure to REAC technology dramatically reduces neuroinflammation, one of the key processes in the disease’s progression.
  3. Cellular Level Studies: The most striking findings have emerged at the molecular level. REAC technology, with specific protocols, has been shown to induce the differentiation of human stem cells into neuronal cells. This discovery opens extraordinary new perspectives for regenerative medicine.
  4. Anti-Senescence Effects: The research has also highlighted that REAC is capable of counteracting the degenerative processes associated with cellular aging, positively influencing markers of senescence.

Conclusions and Future Perspectives

The presented results suggest that REAC technology is more than just a symptomatic approach; it is a therapeutic platform capable of acting on the fundamental biological mechanisms of neurodegenerative diseases. By inducing both neuromodulation and regenerative processes, REAC stands out as an innovative and safe tool poised to revolutionize the treatment of Alzheimer’s and related conditions.

The full article is available here

Did you find this article interesting? Share it!

Subscribe to the newsletter

reac-technology
Home About News
Contact us
© 2026 REAC® All rights reserved
Privacy Policy Terms of Use and Legal Notice
Manage Cookie Credits

Dr. Vania Fontani

dr-vania-fontani-rinaldi-fontani-institute

Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.

She has dedicated her career to research and the development of innovative technologies for human well-being.

Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.

In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.

Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity

Learn more:
• Publications: PubMed – Rinaldi S, Fontani V

Prof. Salvatore Rinaldi

dr-salvatore-rinaldi-rinaldi-fontani-institu

Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316

Profile and Mission

Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.

 

Research Milestones

Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:


Regenerative Medicine:

  • Direct cellular reprogramming through epigenetic modulation of
    endogenous bioelectrical activity with REAC technology.
  • Radiofrequency energy loop primes cardiac, neuronal, and skeletal muscle
    differentiation in mouse embryonic stem cells: a new tool for improving tissue
    regeneration. Cell Transplant. 2012;21(6):1225-33. doi: 10.3727/096368911X600966.
  • Radio electric conveyed fields directly reprogram human dermal skin fibroblasts
    toward cardiac, neuronal, and skeletal muscle-like lineages. Cell Transplant.
    2013;22(7):1227-35. doi: 10.3727/096368912X657297.
  • Neurological morphofunctional differentiation induced by REAC technology in PC12. A
    neuro protective model for Parkinson's disease. Sci Rep. 2015 May 15:5:10439. doi:
    10.1038/srep10439.

Anti-Senescence and Longevity:

  • REAC technology and hyaluron synthase 2, an interesting network to slow down stem
    cell senescence. Sci Rep. 2016 Jun 24:6:28682. doi: 10.1038/srep28682.
  • Stem cell senescence. Effects of REAC technology on telomerase-independent and
    telomerase-dependent pathways. Sci Rep. 2014 Sep 16:4:6373. doi:
    10.1038/srep06373.
  • Anti-senescence efficacy of radio-electric asymmetric conveyer technology. Age
    (Dordr). 2014 Feb;36(1):9-20. doi: 10.1007/s11357-013-9537-8.

Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:

  • REAC technology modifies pathological neuroinflammation and motor behaviour in an
    Alzheimer's disease mouse model. Sci Rep. 2016 Oct 24:6:35719. doi:
    10.1038/srep35719.
  • Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a
    Mouse Model of Neurodegeneration. Neurosci Bull. 2018 Apr;34(2):270-282. doi:
    10.1007/s12264-017-0188-0

Scientific Vision

Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.

Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V